Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,766,000 | 2,783,000 | 5,309,000 | 5,257,000 | 3,626,000 |
| Depreciation Amortization | 888,000 | 445,000 | 1,501,000 | 1,132,000 | 753,000 |
| Income taxes - deferred | N/A | N/A | 1,242,000 | N/A | N/A |
| Accounts receivable | -805,000 | -681,000 | -391,000 | -163,000 | -167,000 |
| Accounts payable and accrued liabilities | 12,000 | 191,000 | 425,000 | 444,000 | -530,000 |
| Other Working Capital | -1,412,000 | -727,000 | 93,000 | 67,000 | -690,000 |
| Other Operating Activity | 2,062,000 | 634,000 | 1,781,000 | 639,000 | 1,113,000 |
| Operating Cash Flow | $5,511,000 | $2,645,000 | $9,960,000 | $7,376,000 | $4,105,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -233,000 | -119,000 | -529,000 | -347,000 | -221,000 |
| Net Acquisitions | -401,000 | -372,000 | -308,000 | -180,000 | -100,000 |
| Purchase Of Investment | -637,000 | -267,000 | -2,230,000 | -1,838,000 | -1,391,000 |
| Sale Of Investment | 1,511,000 | 311,000 | 2,793,000 | 1,890,000 | 1,346,000 |
| Investing Cash Flow | $240,000 | $-447,000 | $-274,000 | $-475,000 | $-366,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 3,111,000 | -33,000 | 23,000 | 423,000 | 23,000 |
| Debt Repayment | -3,013,000 | -7,000 | -25,000 | -18,000 | -13,000 |
| Common Stock Issued | 64,000 | 62,000 | 254,000 | 214,000 | 149,000 |
| Common Stock Repurchased | -8,947,000 | -1,431,000 | -1,410,000 | -905,000 | -900,000 |
| Dividend Paid | -2,668,000 | -1,137,000 | -4,107,000 | -3,077,000 | -2,051,000 |
| Other Financing Activity | -34,000 | 37,000 | -247,000 | -221,000 | 18,000 |
| Financing Cash Flow | $-11,487,000 | $-2,509,000 | $-5,512,000 | $-3,584,000 | $-2,774,000 |
| Exchange Rate Effect | -20,000 | 15,000 | 29,000 | 29,000 | 23,000 |
| Beginning Cash Position | 9,303,000 | 9,303,000 | 5,100,000 | 5,100,000 | 5,100,000 |
| End Cash Position | 3,547,000 | 9,007,000 | 9,303,000 | 8,446,000 | 6,088,000 |
| Net Cash Flow | $-5,756,000 | $-296,000 | $4,203,000 | $3,346,000 | $988,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,511,000 | 2,645,000 | 9,960,000 | 7,376,000 | 4,105,000 |
| Capital Expenditure | -233,000 | -119,000 | -529,000 | -347,000 | -221,000 |
| Free Cash Flow | 5,278,000 | 2,526,000 | 9,431,000 | 7,029,000 | 3,884,000 |